ERBB2 and triple-negative breast carcinoma: Triple-negative breast cancer (TNBC), which is distinguished by the absent expression of human epidermal growth factor receptor 2 (Her2) and estrogen receptor/progesterone receptor (ER/PR), is the most invasive subtype with the highest mortality rate accounting for approximately 15% of all BRCA (2).